Eli Lilly and Company (LLY) Ownership
LLY ownership summary
as of October 18, 2026- Institutions
- 85.4% of shares outstanding
- Insiders
- 0.16% of shares outstanding
- Shares outstanding
- 891.7M
- Float
- 888.9M shares available to trade
- Short interest
- 0.79% 7.0M shares short
- Days to cover
- 3.01 short interest down 10.9% vs prior month
- Institutions 85.36%
- Insiders 0.16%
- Other investors 14.48%
LLY top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Lilly Endowment Inc | 10.14% | 90.4M | $113.61B | −1.5M (−1.7%) | June 30, 2026 |
| 2 | BlackRock Inc | 7.58% | 67.5M | $84.90B | +1.2M (+1.7%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 6.01% | 53.5M | $67.29B | +167,094 (+0.3%) | June 30, 2026 |
| 4 | PNC Financial Services Group Inc | 5.76% | 51.3M | $64.51B | −6,188 (−0.0%) | June 30, 2026 |
| 5 | State Street Corp | 4.06% | 36.2M | $45.52B | +605,752 (+1.7%) | June 30, 2026 |
| 6 | FMR Inc | 3.19% | 28.5M | $35.78B | +2.1M (+8.1%) | June 30, 2026 |
| 7 | Capital Research Global Investors | 2.34% | 20.9M | $26.24B | −3.8M (−15.3%) | June 30, 2026 |
| 8 | Vanguard Portfolio Management, LLC | 2.34% | 20.9M | $26.22B | −117,810 (−0.6%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 2.28% | 20.3M | $25.53B | +118,994 (+0.6%) | June 30, 2026 |
| 10 | Morgan Stanley - Brokerage Accounts | 1.82% | 16.2M | $20.40B | +788,940 (+5.1%) | June 30, 2026 |
| 11 | Capital World Investors | 1.78% | 15.9M | $19.99B | +280,829 (+1.8%) | June 30, 2026 |
| 12 | T. Rowe Price Associates, Inc. | 1.56% | 13.9M | $17.49B | −80,385 (−0.6%) | June 30, 2026 |
| 13 | JPMorgan Chase & Co | 1.41% | 12.6M | $15.84B | −1.1M (−8.0%) | June 30, 2026 |
| 14 | NORGES BANK | 1.29% | 11.5M | $14.42B | −603,469 (−5.0%) | June 30, 2026 |
| 15 | Bank of America Corp | 1.26% | 11.3M | $14.17B | +148,411 (+1.3%) | June 30, 2026 |
| 16 | Wellington Management Company LLP | 1.23% | 11.0M | $13.83B | −2.4M (−18.1%) | June 30, 2026 |
| 17 | State Farm Mutual Automobile Ins Co | 1.21% | 10.8M | $13.52B | — | June 30, 2026 |
| 18 | PRIMECAP Management Company | 1.03% | 9.2M | $11.53B | −50,528 (−0.5%) | June 30, 2026 |
| 19 | Northern Trust Corp | 0.99% | 8.8M | $11.06B | −30,698 (−0.3%) | June 30, 2026 |
| 20 | The Goldman Sachs Group Inc | 0.86% | 7.7M | $9.62B | +1.3M (+20.7%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 6.7M shares and 10 cut 9.7M.
LLY top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.02% | 26.9M | $33.86B | −52,473 (−0.2%) | August 31, 2026 |
| 2 | Vanguard 500 Index Investor | 2.36% | 21.0M | $26.42B | +390 (+0.0%) | September 30, 2026 |
| 3 | iShares Core S&P 500 ETF | 1.20% | 10.7M | $13.40B | −17,168 (−0.2%) | September 30, 2026 |
| 4 | Fidelity 500 Index | 1.15% | 10.3M | $12.91B | +39,439 (+0.4%) | August 31, 2026 |
| 5 | State Street® SPDR® S&P 500® ETF | 1.10% | 9.8M | $12.34B | — | September 30, 2026 |
| 6 | Vanguard MStar Growth Index Investor | 0.99% | 8.8M | $11.09B | +22,694 (+0.3%) | September 30, 2026 |
| 7 | American Funds Growth Fd of Amer A | 0.83% | 7.4M | $9.34B | −930,128 (−11.1%) | September 30, 2026 |
| 8 | State Street®HlthCrSelSectSPDR®ETF | 0.64% | 5.7M | $7.13B | +17,648 (+0.3%) | September 30, 2026 |
| 9 | Vanguard PRIMECAP Inv | 0.61% | 5.4M | $6.81B | −29,393 (−0.5%) | June 30, 2026 |
| 10 | Vanguard Dividend Appreciation ETF | 0.51% | 4.5M | $5.69B | +49,088 (+1.1%) | September 30, 2026 |
| 11 | Vanguard Institutional Index I | 0.47% | 4.2M | $5.32B | +3,659 (+0.1%) | September 30, 2026 |
| 12 | American Funds Invmt Co of Amer A | 0.44% | 4.0M | $4.97B | −561,959 (−12.4%) | September 30, 2026 |
| 13 | American Funds American Balanced A | 0.39% | 3.5M | $4.40B | −22,971 (−0.7%) | September 30, 2026 |
| 14 | American Funds Washington Mutual A | 0.38% | 3.4M | $4.30B | −319,912 (−8.6%) | September 30, 2026 |
| 15 | Fidelity Contrafund | 0.34% | 3.0M | $3.81B | −11,859 (−0.4%) | August 31, 2026 |
| 16 | iShares Russell 1000 Growth ETF | 0.34% | 3.0M | $3.76B | −2,058 (−0.1%) | September 30, 2026 |
| 17 | Vanguard Health Care Inv | 0.32% | 2.9M | $3.60B | −797,382 (−21.8%) | June 30, 2026 |
| 18 | American Funds American Mutual A | 0.32% | 2.8M | $3.56B | −709,386 (−20.0%) | September 30, 2026 |
| 19 | American Funds AMCAP A | 0.31% | 2.8M | $3.52B | −871,463 (−23.7%) | September 30, 2026 |
| 20 | JPMorgan Large Cap Growth I | 0.30% | 2.7M | $3.34B | +320,803 (+13.7%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
LLY insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | Gilbert Ray Cisneros, Jr. | Sell | $985.10 | — | — |
| 2026-02-26 | David Taylor | Buy | $1,022.16 | — | — |
| 2026-02-13 | Angus S. King Jr. | Sell | $1,040.12 | — | — |
| 2026-02-09 | David Taylor | Sell | $1,045.08 | — | — |
| 2026-01-23 | Ro Khanna | Buy | $1,065.05 | — | — |
| 2026-01-16 | David Taylor | Sell | $1,038.26 | — | — |
| 2025-12-29 | Angus S. King Jr. | Buy | $1,078.72 | — | — |
| 2025-12-29 | Markwayne Mullin | Buy | $1,078.72 | — | — |
| 2025-12-18 | Julie Johnson | Sell | $1,056.57 | — | — |
| 2025-12-10 | David Taylor | Sell | $993.51 | — | — |
| 2025-11-21 | John Boozman | Sell | $1,058.05 | — | — |
| 2025-11-18 | Gilbert Ray Cisneros, Jr. | Buy | $1,030.49 | — | — |
| 2025-11-13 | Julie Johnson | Sell | $1,022.00 | — | — |
| 2025-11-07 | Ro Khanna | Sell | $923.35 | — | — |
| 2025-10-24 | Shelley Moore Capito | Buy | $825.86 | — | — |
| 2025-09-23 | Val T. Hoyle | Sell | $747.29 | — | — |
| 2025-08-26 | Ro Khanna | Sell | $734.93 | — | — |
| 2025-08-22 | John Boozman | Buy | $710.73 | — | — |
| 2025-08-14 | Julie Johnson | Sell | $685.27 | — | — |
| 2025-08-14 | David Taylor | Buy | $685.27 | — | — |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LLY shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LLY
Institutional investors own 85.4% of Eli Lilly's shares and insiders 0.16%. The largest holder is Lilly Endowment Inc with 10.14% of the shares (90.4M), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 10 reduced their stake in the latest filings. Short interest is 0.79% of the float, or 3.01 days of average trading volume. The share count fell 19.1% since 2014.
Related: LLY analyst forecast, LLY key metrics, LLY dividend history. See the LLY stock overview for the latest quote and news.
LLY ownership FAQ
Who owns the most Eli Lilly stock?
The largest shareholders of Eli Lilly are Lilly Endowment Inc (10.14%), BlackRock Inc (7.58%), Vanguard Capital Management, LLC (6.01%), PNC Financial Services Group Inc (5.76%), State Street Corp (4.06%).
What percentage of Eli Lilly is owned by institutions?
Institutions hold 85.4% of Eli Lilly's shares outstanding; insiders hold 0.16%.
Which funds own Eli Lilly?
The largest fund holders of Eli Lilly are Vanguard MStar Total Stk Mkt Idx Invest (3.02%), Vanguard 500 Index Investor (2.36%), iShares Core S&P 500 ETF (1.20%), Fidelity 500 Index (1.15%), State Street® SPDR® S&P 500® ETF (1.10%).
What is Eli Lilly's short interest?
7.0M shares of Eli Lilly were sold short, 0.79% of the float; at the average daily volume it would take 3.01 days to cover.
Are insiders buying or selling Eli Lilly?
Of the latest 20 reported insider transactions in Eli Lilly (since August 14, 2025), 8 were purchases and 12 were sales.
How many shares of Eli Lilly are outstanding?
Eli Lilly has 891.7M shares outstanding, of which 888.9M are in the public float.